Multiple Sclerosis, Chronic Progressive
Semantic Scholar uses AI to extract papers important to this topic.
No drug has been found to have any impact on progressive multiple sclerosis (MS). Biotin is a vitamin acting as a… Expand In experimental animal models of multiple sclerosis demyelinating antibody responses are directed against the myelin… Expand A 2-year, placebo-controlled, double-blind, crossover study was started in 1992 to evaluate cladribine, an immunosuppressive drug… Expand A randomized, double‐blinded, placebo‐controlled, clinical trial of low‐dose, weekly, oral methotrexate was performed in 60… Expand Chronic progressive multiple sclerosis (MS) is a severely disabling demyelinating disease in which autoimmune processes seem to… Expand Magnetic resonance imaging is a highly sensitive method for the detection of the lesions of multiple sclerosis and renders… Expand BACKGROUND
Cachectin, or tumor necrosis factor-alpha (TNF-alpha), is a principal mediator of the inflammatory response and may be… Expand Patients with clinically definite multiple sclerosis, mild to moderately severe neurological disability (entry score on the… Expand Forty-four patients with chronic progressive multiple sclerosis (MS) were compared with age- and education-matched control groups… Expand In an analysis of pooled data, we have found that cytotoxic-suppressor T cells outnumber the helper-inducer subset and also the… Expand